NPCE
NeuroPace IncCompany with tickers: NPCE
CIK
1528287
CUSIP
641288105
Shares Outstanding
34,093,745
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $22,068,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | $18,048,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Expenses | $23,616,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $7,189,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-5,568,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-6,689,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.20 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.20 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |